TSTL Interim

25/07/2023 Tristel Shareholder Open Day 2023 Presentation accompanying slides
25/07/2023 Tristel Shareholder Open Day 2023 Presentation
06/06/2023 FDA Approval Presentation
03/06/2023 North America Business Plan
06/03/2023 Tristel – Half Year Results 2022
21/02/2023 TSTL Interim Results Investor Presentation
28/10/2022 Preliminary Results Investor Presentation
25/10/2022 Investor Presentation
25/07/2022 Investor Day Webinar
18/07/2022 Shareholder Open Day
18/05/2022 Investor Presentation accompanying slides
18/05/2022 Investor Presentation video
21/02/22 Webinar recording
21/02/22 Interim Results Presentation
25/10/2021 Preliminary Results Presentation
18/10/2021 Investor Presentation
02/03/2021 Interim Q&A
22/02/2021 TSTL Interim
19/10/2020 Final Results Introduction
22/07/2020 Tristel Open Day – Q&A
22/07/2020 Virtual Shareholder Open Day Financial Review Slides
22/07/2020 Virtual Shareholder Open Day
30/06/2020 Preliminary Results Presentation
24/02/2020 Interim Results Presentation
01/08/2019 Open Day 2019
23/07/2019 Shareholder Open Day Presentation
30/06/2019 Preliminary Results Presentation
25/02/2019 Interim Results Presentation
17/07/2018 Shareholder Open Day Presentation
30/06/2018 TSTL Investor Presentation
31/12/2017 Investor Presentation – Interim Results
19/07/2017 Investor Open Day Presentation & Script
30/06/2017 TSTL-Preliminary Results Investor Presentation
31/12/2016 Interim Results Presentation
31/12/2016 TSTL Investor Presentation
22/07/2016 Investor Open Day Presentation
22/07/2016 Running Order
30/06/2016 Preliminary Results Presentation
30/06/2016 TSTL Investor Presentation
31/12/2015 TSTL Interims Results Presentation
31/12/2014 TSTL Interims Results Presentation
01/10/2020 Investor Presentation 2020